President at Isosceles Pharmaceuticals - Wilmington, NC, US
Chief Strategy Officer
Contact Deborah Mosca
Chief Regulatory Officer
Contact Mark Mannebach
Chief Executive Officer
Contact William Humphries
Chief Medical Officer
Contact Andrew Barrocas
Contact Herbert Neuman
Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.